Stay updated on Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Displays that recruitment is closed for the trial, and updates the study history with a new revision tag (v3.6.0) while removing the older v3.5.5 tag.
    Difference
    0.4%
    Check dated 2026-06-11T23:19:39.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.5' was added to the history. The previous 'Revision: v3.5.4' entry was removed, reflecting an update to the page's record history.
    Difference
    0.1%
    Check dated 2026-06-05T00:12:32.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is displayed instead of v3.5.3 on the page, indicating a minor system update to the Study History page.
    Difference
    0.1%
    Check dated 2026-05-21T13:46:17.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Pfizer terminated the MagnetisMM-4 umbrella study and will not pursue the Phase 2 expansion, changing its status to Terminated; the termination note specifies it was not due to safety concerns or regulatory requests.
    Difference
    0.5%
    Check dated 2026-04-30T03:25:03.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page revision label changes from v3.5.0 to v3.5.2, with no other study record content updates shown.
    Difference
    0.1%
    Check dated 2026-04-22T18:14:56.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added to the history. An earlier revision v3.4.3 was removed from the list.
    Difference
    0.1%
    Check dated 2026-03-25T01:22:27.000Z thumbnail image

Stay in the know with updates to Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial page.